← FDA Drug Approvals (Drugs@FDA)

DEFLAZACORT

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TRIS PHARMA INC · Approved 2024-04-25

Drug application

FDA Application #

ANDA217813

Application type

Abbreviated New Drug Application (Generic)

Brand name

DEFLAZACORT

Generic name

DEFLAZACORT ORAL

Active ingredients

DEFLAZACORT

Dosage form

SUSPENSION

Route

ORAL

Marketing status

Prescription

Sponsor

TRIS PHARMA INC

Manufacturer

Cranbury Pharmaceuticals, LLC

First approval

2024-04-25

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown